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Abstract: Despite global awareness of the key factors surrounding antimicrobial resistance (AMR),
designing and implementing policies to address the critical issues around the drivers of AMR remains
complex to put into practice. We identified prevalent narratives and framing used by epistemological
communities involved in the response to AMR in Tanzania, interrogated how this framing may inform
policymaking, and identified interventions that could be tailored to the groups believed responsible
for AMR. We interviewed 114 key informants from three districts and analysed transcripts line by line.
Our results suggest that many different groups help drive the spread of AMR in Tanzania and need
to be involved in any effective response. Human health is currently perceived as driving the response,
while other domains lag behind in their efforts. For AMR programmes to be successful, all sectors
need to be involved, including civil society groups, community representatives, and those working
in communities (e.g., primary care physicians). However, current plans and programmes largely fail
to include these viewpoints. The perceived presence of political will in Tanzania is a significant step
towards such a response. Any strategies to tackle AMR need to be tailored to the context-specific
realities, taking into account constraints, beliefs, and power dynamics within countries.
Keywords: antimicrobial resistance; Tanzania; drivers; qualitative analysis; policy
1. Introduction
While global awareness of the key drivers involved in antimicrobial resistance (AMR)
exists, designing and implementing policies to address these critical issues is complex
and must take into account many different factors. The situation is complicated by many
factors, including political will, poverty, lack of understanding in communities and by
experts, siloing of the various fields that need to take responsibility for both policy-setting
and implementation (human, animal, and environmental health), and conflicts of interest.
Preventing over- and misuse of antimicrobials needs to be balanced against ensuring
equitable access, so that those who need them get them appropriately [1]. A further issue
is that of counterfeit or substandard drugs, which are often widely available in markets
and pharmacies in low- and middle-income countries (LMIC) [2]. Numerous stakeholders
from the public, private, and civic sectors are involved in both perpetuating and potentially
solving the problem, and lack of cooperation among these stakeholders may complicate
AMR even further. For example, clinicians may be influenced to prescribe unnecessary
antibiotics by pharmaceutical companies, and this type of conflict of interest needs to be
strictly regulated [3]. Untangling these conflicts and setting priorities is not simple.
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In February 2016, Tanzania was the seventh country to undergo a Joint External
Evaluation (JEE) to examine preparedness to address public health threats, including
AMR [4]. Tanzania had the lowest score (1) on three of the four AMR indicators (AMR
detection, surveillance of infections caused by antimicrobial-resistant pathogens, and
antimicrobial stewardship activities) and a score of 3 on the fourth (healthcare-associated
infection prevention and control programmes). A score of 1 suggests no capacity, while a
score of 3 reflects developed capacity. A score of 4 is the minimum desired target, indicating
functionality and sustainability [5]. According to the JEE, many antimicrobials are used
inappropriately in the animal and human health sectors in Tanzania, and no system is in
place to collect data on the prevalence of resistance in common pathogens [4].
The Tanzanian National Action Plan (NAP) on AMR 2017–2022 was finalised in
April 2017 and details actions to be taken to address issues around AMR [6]. The main
points covered are the need to increase public awareness and promote behaviour change,
strengthen surveillance and research, improve infection prevention and control systems,
and improve the regulatory framework around antimicrobial agents to promote better
stewardship of these drugs.
Effective implementation of the NAP in Tanzania is complicated by many familiar
factors including (i) over-the-counter sales of antibiotics without a prescription [7], (ii) lack
of effective regulation of antimicrobial use in animals and humans [8], (iii) over- and misuse
of antimicrobials in livestock [9–11], (iv) poor surveillance [12], (v) self-medication [13], and
(vi) the fundamental issue of lack of awareness of the existence of the Tanzanian NAP for
AMR [12]. The key is to ensure appropriate access to antimicrobials while reducing overall
use and promoting awareness in One Health practitioners and communities alike. One
reported strength in Tanzania is the political commitment to addressing AMR, supported
by leadership from the national government, which is helping to drive the coordination of
effective interventions and efficient allocation of resources in the country [14].
Frames ‘define problems [ . . . ] diagnose causes [ . . . ] make moral judgments [ . . . ]
and suggest remedies’ [15]. Framing is used to suggest that some elements of a ‘reality’
are more important than others, thereby positing a salient interpretation or definition of a
policy problem, the drivers behind it, and possible solutions, which can work in favour of
a particular group [16]. Framing is, thus, key to policymaking as it informs understandings
and perceptions of actors’ positions, legitimises their behaviour, and becomes a tool to
challenge or reinforce power relations, with major implications for the success or failure of
policies. Policymakers may use frames, deliberately or unconsciously, to construct a view of
the world that is instrumental for them, allowing them to gain legitimacy and influence over
the policymaking process [17]. A recent paper examining policy documents on AMR in
Pakistan concluded that the framing used in these documents reflected relationships among
various powerful groups of actors in the country and were likely designed to serve their
interests in an attempt to influence the policymaking process [18]. Wernli and colleagues
identified five predominant frames used in policy documents addressing AMR: AMR as
a healthcare problem, as a development issue, as an innovation challenge, as a security
issue, and as a One Health challenge [19]. They found that, although coherent, none of the
frames alone was complex enough to describe and explain AMR, and who authored each
document influenced the frames used. Policy innovation requires a clear understanding of
the different frames used, how these frames reflect values and potential interests, and how
they inform the priorities of the policymaking process for each epistemological community.
Although AMR is often framed as a One Health issue, with drivers encompassing
human health, animal health, and environmental health domains, it is also reduced to
individual responsibility, with behaviour change cited as a panacea for AMR [20]. Framing
AMR as a lifestyle disease, i.e., a matter of individual choice to take or not to take antibiotics,
is too easy and is not helpful in terms of dealing with the cogent issues.
AMR is framed and constructed in different ways by different groups with different
motives [18,19]. These motives must be taken into account when looking at who is judged
to be responsible for both driving and implementing solutions to AMR. The Social Con-
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struction Framework (SCF) [21] describes how people process information subjectively
according to their internal biases, interests, beliefs, and values. The three key elements
in the framework are (i) social constructions (perceptions of and symbols associated with
different groups), (ii) target populations (who the policy is aimed at), and (iii) power
relations. The SCF recognises that policy options are subjective, socially constructed, and
related to how much power a group is perceived to hold. Understanding who is likely
to influence AMR policymaking is key to constructing effective policy [22]. In this study,
we used the SCF as a basis for our analysis, examining who is held responsible and why,
but developed the idea further by recognising that AMR is multifaceted and that no true
‘target population’ exists, as everyone is a potential target.
Our aims were (i) to identify prevalent narratives and framing used by epistemological
communities involved in the response to AMR in Tanzania (e.g., pharmacists, healthcare
workers, veterinarians), (ii) to interrogate how this framing may inform policymaking, and
(iii) to identify interventions that could be tailored to be effective for the different groups
stated to be responsible for AMR.
2. Results
We interviewed 114 participants. Nine were members of the national Multi-Stakeholders
Committee: one each from the Food and Agriculture Organisation (FAO) of the United Na-
tions Country office, the Ministry of Livestock and Fisheries, and the Tanzania Medicines
and Medical Devices Authority, and six from the Ministry of Health, Community Develop-
ment, Gender, Elderly, and Children. We interviewed 25 laboratory technicians from public
and private healthcare facilities, 23 health facility managers, 19 dispensers, 15 paravets,
12 livestock field officers, and eight pharmaceutical assistants. We also interviewed an
Environmental officer from Ilala Municipality, a pharmacist from Kilosa District Hospital,
and a staff member from an implementing partner.
First, we describe our findings in terms of who the interviewees framed as being re-
sponsible for driving the spread of AMR, including livestock farmers, pharmacies, individ-
ual consumers, medical professionals, local communities (groups of potential consumers),
government, and donors. Second, we describe the actors who interviewees suggested
could or should be responsible for addressing this spread.
2.1. Which Stakeholders Are Framed as Being Responsible for Driving AMR?
2.1.1. Livestock Farmers
Interviewees stated that livestock farmers have little or no understanding of AMR;
consequently, they do not consult veterinary specialists and instead self-treat their animals.
They mentioned that farmers dispose of waste incorrectly and do not keep animal sheds
clean. The predominant framing used was cost; farmers do not listen to veterinary special-
ists because they cannot afford the correct medicines. They use what they have always
used, even if this is a medicine nominally for human use.
‘When you go to provide services to a livestock keeper, let us say he called you to treat a
certain disease which his livestock have, when you provide treatment he will always be
there watching, he copies everything that you are doing, he will take that medicine and
take a good look at it, they don’t know how to read but he will make sure he memorises
it in his mind. So, next time he will do everything himself, so that gives us a challenge
in solving the livestock problem, but we sensitise them many times that, if something
happen, they should involve us.’ [Paravet 1].
‘In the community, people can use a certain drug without professional prescription, so
they may use a certain medicine which in reality is not specific for a disease they intend to
cure. So that creates drug resistance in livestock, and it becomes difficult to cure it [ . . . ]
livestock keepers should listen to livestock officers’ advice on the use of livestock products
when their livestock uses antibiotics. Moreover, they should consult the livestock officer
before using any antibiotic drug so as to reduce the problem of drug resistance and to get
good results, rather than using many drugs at once without professional advice. That
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will create more problems and the government will incur costs to control that problem.’
[Livestock Field Officer 1].
It was reported that farmers are often unable to afford to stop milking their animals or
selling their meat to allow the antibiotic withdrawal period to elapse, which puts antibiotic
residue into the human food chain. Livestock keepers also tend to do what they have
always done and are sometimes not amenable to listening to advice from professionals.
‘Concerning this problem of antimicrobial resistance as I said, since we are at a low level,
we are the ones who know where the problem is. In Europe, this problem is not huge; for
example, if chickens are suffering from Newcastle [disease], the government will take all
the chicken and compensate a livestock keeper, but here we can’t do that. That is why it
is difficult to tell a person to withdraw milk for 14 days when he depends on that milk
for everything, or you can’t stop a person from selling meat just because his livestock is
on antibiotic treatment and it is very difficult to follow up. This is where the problem of
drug resistance in human beings started from.’ [Paravet 2].
‘[ . . . ] Maasai livestock keepers have traditional issues; you may go there with your
professional idea but they don’t take it into consideration [ . . . ] the medicines they use
have no good quality; they buy medicines at the auction where they display medicines in
the sun for almost 5 months but they take that medicine and use it on cows, which causes
resistance and an increase in other unknown diseases, until they come to see you when
the situation will be worse.’ [Livestock Field Officer 2].
2.1.2. Pharmacies
Some interviewees commented on pharmacies illegally selling antibiotics over the
counter without a prescription. This is intertwined with the lack of enforcement of regula-
tions, as pharmacists can be confident that they will not be penalised for these practices.
‘One important thing in our pharmacies is we have policies, but they have not been
enforced to prevent selling of drugs without a doctor’s prescription where the prescription
is based on laboratory test results. Someone goes to the pharmacy and feels they have
a UTI [urinary tract infection], so they buy antibiotics. So, there is a need to have
over-the-counter prescriptions.’ [AMR Programme Coordinator].
One dispenser stated that although in an ideal world doctors should always be
consulted before antibiotics are dispensed, this does not happen in practice.
‘In my opinion, we should keep on educating the community as we are doing. Moreover,
you should help us to educate people who sell medicines in pharmacies that they should
not give clients medicines without a doctor’s prescription [ . . . ] we should control a
system of selling medicines without a doctor’s prescription; that will help to control the
problem of drug resistance [ . . . ].’ [Healthcare provider 1].
This quote illustrates the fact that people are making efforts to educate communities
on the issues around AMR and what they can do to help prevent it spreading.
‘Resistance happens because we have failed to control the sale of medicines in the street;
most people who are selling in street pharmacies have poor medicine knowledge, so there
should be control of medicines.’ [Healthcare provider 2].
2.1.3. Consumers
Many interviewees framed individual consumers as being partly responsible for the
spread of AMR, for example, not finishing a course of antibiotics, but did not often clarify
why they may behave in this way. A representative of the FAO, an agency of the United
Nations, stated that individuals are responsible up to a point, but that the public needs
to be educated to understand why they need to complete the course, as this does not
necessarily make intuitive sense to some people, particularly those with little education.
The next quote suggests that labelling needs to be made more effective and comprehensible
to consumers.
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‘We use the term antibiotics, while the prescription form is written as amoxicillin or
erythromycin. An ordinary citizen can’t understand that [ . . . ] they should instruct
all pharmaceutical industries and importers to add the word ANTIBIOTICS in capital
letters (bolded) so that one knows what I was told when I was prescribed antibiotics and
that I need to complete the dose.’ [FAO representative].
Some interviewees framed AMR as being caused by a lack of individual responsibility,
with patients not finishing the course of antibiotics.
‘I can say that it is caused by use of medicines because, for all the time I have been here, I
realised that most patients don’t finish the dose, so if a patient doesn’t finish a first stage
dose and when they come back, you prescribe them another medicine, they may not finish
that dose.’ [Dispenser 4].
This is obviously linked to a lack of awareness and an understanding of the potential
results of not finishing a course.
‘You may find that a person may come to seek treatment here but after 2 days they
come back. When you prescribe medicines for that client, they tell you that I have those
medicines at home; when you ask them why they didn’t finish a dose, they tell you that,
when they started feeling better, they stopped taking them. So, we have to educate them
that, by doing that, it will cause drug resistance; if that happens, those medicines won’t
be able to cure then anymore since they don’t finish a dose.’ [Dispenser 8].
Furthermore, consumers who are living in poverty may have little choice but to buy
one antibiotic tablet at a time and, thus, are unlikely to complete a prescribed course
of drugs. They may not be able to afford the specific drugs prescribed for them; hence,
pharmacies will dispense a different, possibly less targeted and effective, antibiotic.
‘When patients take the responsibility of going to buy medicines at the pharmacy . . .
if a doctor prescribed ampiclox, when that patient goes to the pharmacy, they say that
the medicine cost is 3000 [Tanzanian shillings] but they have 1500, so they may ask a
pharmacy seller for any other medicine that can help. They take another medicine which
is at a low level compared with the medicine a doctor prescribed, which may also be an
antibiotic but it may not be the right medicine for the disease that the patient has, which
will cause resistance in the end.’ [Healthcare provider 3].
‘[ . . . ] a patient may tell you to prescribe half dose first and that they will come for the
rest; this mainly happens in pharmacies. So, that patient takes half dose by promising
they will come to buy another half dose, but, after finishing the first half dose and feeling
better, they don’t go to buy another half dose, and, when they get sick again, they go back
to the pharmacy and buy a half dose.’ [Healthcare provider 16].
Consumer expectations are also an issue, as people know what worked for them the
last time they were ill, so they ask for these antibiotics at the pharmacy without consulting
a doctor. They need to be made aware that the antibiotic, although it worked once, will not
necessarily work a second time, particularly for a different illness, and this may encourage
resistance as it does not target the illness they are currently experiencing. This is framed
partly as individual responsibility and partly as a need for better or more education.
‘People have been used to the idea that, when they use a certain medicine they get better;
maybe that person was prescribed a certain medicine and that medicine helped them, so
the next time they get sick, they won’t go to see a doctor and will just go to buy that
medicine and use it; so, they will keep taking the same medicine when they feel sick
and, in the end, the disease becomes resistant. So, education should be provided in the
community that they should not be taking medicines regularly [ . . . ].’ [Dispenser 13].
Consumers may also hear about effective drugs from word of mouth, but do not
realise that these drugs need to target their specific illness; it is not one size fits all.
‘However, sometimes, the problem is also patients; a patient may force a doctor to prescribe
them certain medicines just because they were told that those medicines are effective.’
[Environmental Officer].
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One interviewee mentioned that, when issues around the correct selection of antibi-
otics are explained to patients, they do understand, and this is hopefully reflected in their
behaviour, as they take the correct drug. This suggests that, in certain contexts, making
consumers aware may work.
‘That [patients requesting antibiotics] is one of the biggest challenges in treatment; clients
may come with such suggestions, but we usually counsel them on which medicine will
be appropriate according to the sickness they have, and I can say that most clients they
understand when you explain it to them clearly.’ [Healthcare provider 4].
2.1.4. Medical Professionals
All dispensers interviewed stated that the community should be educated about AMR;
none of the dispensers themselves received any specific training on AMR. Many of the
health service provider interviewees, the majority of whom interact with the public on a
daily basis, framed AMR as an issue of individual responsibility.
‘I use the knowledge I acquired at college, for example, to tell a client the importance of
taking medicines on time and the effects of taking medicines without a doctor’s prescrip-
tion. I tell them that they should consult a doctor first before taking medicines so as to
prevent antibiotic resistance.’ [Dispenser 1].
‘You may find that a patient is taking medicine for 3 days only; when they start feeling
better, they stop taking medicine; so, after a certain period of time, they start getting sick
again. Then, they come at the facility and say that they were prescribed medicine but
started feeling sick again. If you ask them questions, you will realise that they didn’t
finish a dose or you may find that they shared the medicines with a relative; so, we tell
them that they should not do that.’ [Healthcare provider 1].
If service providers are educated about AMR, interviewees suggested that they, in
turn, will be able to inform their clients of the relevant issues.
‘More education should be provided to service providers and to the community so that
they can know how to use antibiotics effectively.’ [Dispenser 1].
One interviewee framed AMR as being a result of misuse of antibiotics, but also stated
that some doctors were complicit in the issue and overprescribed in an attempt to earn
extra income.
‘[ . . . ] a person is using medicines without following treatment regime, without knowing
which medicines they should start with, or a person may be described antibiotics when
they can use normal medicines; a patient may have a simple case but a doctor prescribes
many and strong medicines just to earn income [ . . . ].’ [Healthcare provider 5].
Related to this is the issue of doctors prescribing different, possibly less effective drugs
for patients with little money or those who do not have health insurance that would cover
the cost of their medication.
‘[ . . . ] for patients who don’t have health insurance, it is a challenge. Sometimes, a
patient may tell a doctor to prescribe medicine of low cost since they have a small amount
of money. So, you know for sure that this patient won’t afford to pay for ceftriaxone, so
you just prescribe them amoxillin so that they can get relief.’ [Healthcare provider 10].
Interviewees highlighted that doctors should be responsible for dispensing not just
prescriptions but also advice to their patients. Doctors are widely respected in commu-
nities, which can mean that, when pharmacies have run out of specific drugs a doctor
has prescribed, consumers are not willing to accept a substitution that would be equally
effective. The same trust they have for doctors is not shown for pharmacists.
‘When a patient comes, they should be educated, and doctors should listen to a patient’s
previous medication treatment so that, if possible, a patient can be given a different
medicine. Patients trust doctors so much, so when they come to the dispensary and you
tell them that we don’t have this medicine and we will give you another medicine, some
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patients refuse. Sometimes, they go back to a doctor to show the medicines we gave them;
so, they should be educated.’ [Dispenser 11].
One interviewee was adamant that medicine has become a business rather than a
vocation. This leads to irresponsible prescribing, whereby medical professionals can earn
more income, and this in turn is fuelling the spread of AMR as patients are prescribed
medications that are ineffective for their specific illness. This is compounded by the fact that
doctors sometimes do not listen to what a patient is telling them; they are more interested
in getting the next patient into the room and earning another consultation fee.
‘[ . . . ] Nowadays, most of the doctors are doing business; now, a patient can go to a
doctor’s office and start giving a doctor instructions on which medicines they want;
sometimes a doctor won’t concentrate when a patient is talking as they are busy with
other things. A patient may be telling a doctor which medicines they have used but a
doctor doesn’t listen, so they will just attend to a patient quickly so that they can leave.’
[Environmental Officer].
Public and private practice also complicates the issues. One doctor suggested that
private medical practices pursue profit and are maybe less likely to follow guidelines, even
when these exist.
‘For government hospitals, I think there are positive results [with guidelines] but, for
private hospitals, I think there won’t be positive results since they are business-oriented.’
[Healthcare provider 5].
Participants mentioned that doctors should routinely run resistance tests, but these are
expensive and individuals may not be able to afford them; hence, doctors have no option
but to prescribe as they see fit. One interviewee suggested that the Ministry of Health
needs to ensure that inexpensive testing options are available so that they are affordable
by everyone.
‘In my opinion, there should be a procedure of conducting tests on patients and to
prescribe them appropriate medicines according to the bacteria they have rather than
prescribing medicines regularly. Sometimes, patients may be given a certain medicine
for UTI; when it fails, the doctor tries another medicine and, when that medicine fails,
they try another medicine again. So, it will be better if we conduct a culture test so
as to provide appropriate medication [ . . . ] I think the ministry should improve this
because medication touches people’s lives; so, they should consider reducing the cost for
culture test since not all people can afford culture tests at 150,000 or 70,000 [Tanzanian
Shillings].’ [Healthcare provider 6].
Even when testing facilities do exist, doctors may not use these, which may be related
to a lack of awareness of both the health professionals and the general public regarding the
importance of testing to ensure that patients are prescribed an antibiotic that is going to be
effective for them.
‘Even in our big hospitals, people are being prescribed medication without any tests. So,
we need to sensitise people to make sure that, for each drug we dispense, we take a sample
for culture and sensitivity tests in order to either continue with the drug or substitute
depending on the results.’ [Ministry of Health official].
2.1.5. Local Communities
It was suggested that local communities have not been involved in the design of
the AMR national plan or invited to comment on its contents, and they have not been
provided with awareness campaigns. Instead, the process was run by technocrats and
health professionals with no input from service users at whom some of the NAP objectives
are targeted.
‘I’m not sure about the community involvement. In the sessions I attended, I did not see
a participant specifically from the community.’ [Ministry of Health official].
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However, one interviewee mentioned that, now that the NAP is in place, certain
specific communities are becoming more engaged and involved.
‘The community from the grass roots, for example, livestock keepers or farmers, was
not involved; it was difficult. Now, there is engagement because there are livestock
keeper associations, so it is easy to get representatives; however, there were no such
associations back then, so it was hard to get representatives.’ [Ministry of Livestock
and Fisheries representative].
2.1.6. Government
Interviewees often stated that AMR policies prioritise human rather than animal or
environmental health, and this was reflected in the fact that the human health sector was
more involved in designing the NAP.
‘[ . . . ] environmental people see that the environmental issue isn’t covered much although
we included waste management. So, if you read the plan, the area which isn’t much
covered is the environment.’ [TMDA Medicines Coordinator].
‘When you talk about these issues involving more than one sector, the human health
sector has often taken a big part (okay); even in this exercise, it took a big part; even in
the plan, it took a big part. However, at the end of the day, it has to touch other sectors
because they provide a response to human health. Human health is leading because it is a
priority.’ [FAO representative].
There was a perceived lack of coordination among the different sectors, which remain
in their silos and do not easily work together. This results in a duplication of effort.
‘We have one health desk even though all the organisations have not been streamlined to
work together. One of the efforts we have put in place is to have this MCC [Multisectoral
Coordination Committee] session with some technical committees, but other sectors are
not involved. You can’t blame anyone because that’s how our system has been from the
beginning. Everyone is working alone and, at the end of the day, you get duplication of
effort because of not working together. Even in terms of administration, each organisation
has its own leader, which is very challenging.’ [AMR Program Coordinator].
Participants emphasised that policies that do exist are not enforced effectively, which
drives the spread of AMR. This lack of regulation may also mean that AMR is not accepted
as a serious issue, as, if it was, the government would be addressing the problem. However,
one interviewee, while agreeing that enforcement is an issue, argued that education needs
to come first, as, if communities do not know what is required of them, they will not be
able to comply.
‘As I said, we should enact laws that will enforce people to do what is required. It is
not an issue of like or not, it is a legal issue. However, people should not be forced
by the law without being educated. Provision of education should come first; people
should be told what is required and the consequences to make it easier to monitor.’
[FAO representative].
Another interviewee stated that sufficient laws exist but that enforcement of these is
lacking, and that it is the government’s responsibility to rectify this situation.
‘Enforcement. If you look there are laws everywhere that are not followed. So, the
government and responsible authorities overseeing this area should ensure enforcement
is done.’ [TMDA Medicines Coordinator].
One interviewee suggested that the government should enforce inspection of street
medicine shops, which are currently unregulated, to try and ensure that consumers receive
the medicines they have actually been prescribed by a medical professional.
‘When you talk about the hospital, it means guidelines, but do people who sell medicines in
the street use guidelines? When a patient comes here, we give them medicines according
to the guideline, but, after some time, that patient suffers from the same problem, then
you realise that they were given another medicine at the street medicine shop. If the
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government doesn’t have a system of conducting inspection of medicine shops to see
if they follow procedures in dispensing medicines, this problem won’t end [ . . . ] The
government should form a team to investigate if people are given proper medication, to
investigate if pharmacies dispense medicines by considering the doctor’s prescription.’
[Healthcare provider 2].
Lack of enforcement of policies was also noted in animal health. The next quote
illustrates some of the challenges described by our participants. In this case, the intervie-
wee explained that, similarly to the human health sector, policies that do exist around
antibiotic sales to livestock farmers are not enforced or implemented. They suggest that the
government should clarify who is able to sell antibiotics, and where they can sell these.
‘I think there are those policies at the livestock department even though they are not
implemented because there is a free market for medicines; a Maasai sells medicines to
his fellow Maasai, so there is a policy, but the implementation is weak. For example,
when you go to the livestock auction and tell people to stop selling medicines unless they
have a licence, they will tell you that, at other auctions, people sell medicine so you can’t
control them. So, there are policies but there is no policy management; however, if the
government would release a statement that a livestock keeper is not permitted to sell
certain medicines including antibiotics and vaccines, things would be better.’ [Livestock
Field Officer 3].
2.1.7. Donors
There was a perceived lack of donor funding and lack of coordination among the
different sectors. One interviewee commented that the AMR agenda is donor-driven, and,
when organisations leave a country, the situation becomes complicated, especially if there
is not enough domestic funding to continue programmes.
‘We are supposed to know all stakeholders who participate in AMR, but we don’t and
we have to know them for mapping. Another challenge is that, for the environment, it
is not well coordinated and needs extra effort. Another challenge is insufficient funds
compared to existing activities. If I look clearly, I see that this AMR is more of a donor-
funded project than a government-funded one, so when donors leave, the situation will be
difficult.’ [TMDA Medicines Coordinator].
However, another interviewee stated that the Ministry of Health is cognisant of
issues around financial support from donors, and a budget now exists to facilitate
plan implementation.
‘The main challenge which faces many areas is a lack of funding, because plan implemen-
tation needs money in one way or another; most of the time, we depend on donor support,
but we are thankful that now our government has given the health ministry priority in
terms of budget.’ [Healthcare provider 22].
2.2. Who Is Framed as Having the Ability to Tackle AMR?
The Tanzanian Ministry of Health was described by most interviewees as the pivotal
stakeholder in the development of a response to AMR, which is consistent with the framing
of AMR as predominantly a human health issue that should drive policymaking. Other
actors mentioned included the FAO, WHO, and TMDA.
Three interviewees commented that political will is present and that the Ministry of
Health is an effective policymaker, having designed a budget to accommodate recommen-
dations from the NAP without relying on external funds from donors.
‘The success that I currently see is political will; the government has taken this seriously.
However, the issues of governance are also why we now have had MCC sessions to
coordinate everything that is happening in the country regarding antimicrobial resistance.
This is good because things are run in order and not arbitrary. Moreover, a government
commitment is needed, where the government does not rely solely on donations from
donors like FAO, WHO, and others. However, in this session, we also said that they
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should allocate a budget in their annual plans. It is the government’s commitment
that, even if these projects do not exist, the AMR will continue to be implemented.’
[FAO representative].
Another interviewee commented that political will exists in Tanzania, and this is
crucial for communities to listen and adopt practices that are designed to help control AMR.
‘One of the successes is that there is political will; you know, in all health programs,
you must first get political will or political commitment. So when, you get political
commitment, that is a very big success because high-level leaders are the ones who plan
national strategies; they have national vision, and they take that matter as a priority. So,
they may even allocate a budget, and a high-level leader may talk about it. In involving
the community, when I go to talk with the community, they may not listen, but, when a
member of parliament or the ministry goes to talk to people, they will listen; that is a big
advantage of political will.’ [Healthcare provider 22].
The government is perceived as an active partner in the response to AMR, with one
interviewee commenting that the Ministry of Health in particular has been at the forefront
of the response.
‘However, in general, the health ministry had a very big contribution because they were
involved in situation analysis to see what is missing and what is not giving good results
for some infections. So, we gathered a lot of information from that sector.’ [Ministry of
Livestock and Fisheries representative].
A second interviewee echoed the key role of the Ministry of Health, which is leading
the response to AMR in Tanzania.
‘In reality, this issue is managed by the health ministry; its source is the health ministry,
people think that the issue of antimicrobial resistance concerns human beings only, the
health ministry is the one managing human health, the leader of the central committee
comes from the health ministry, and the secretariat is formed by many people from the
health ministry; therefore, since we said it is a one health concept, the health ministry
must take leadership responsibility to incorporate people from other sectors like wild
animals into this issue.’ [Healthcare provider 22].
One interviewee stated that the government is effectively educating the general public
on the risks around AMR and taking antibiotics in particular.
‘So, we educate them that it is not a good thing to take medicines without testing.
Moreover, sometimes cars pass in street to announce that not all fevers are malaria fevers.
The government is doing a good job in that area; people are being told that they should
not use medicines without testing, and we tell them that antibiotics are very, very strong.’
[Laboratory 4].
The FAO presents itself as having an advisory role and potentially providing various
types of support to the government.
‘The FAO is there for providing support. We, therefore, advise the country about things
which are happening and things that will happen. We are ready to provide support in
terms of technical and financial.’ [FAO representative].
The WHO was also mentioned as a key actor in the efforts to prevent the spread of
AMR, working in conjunction with the Ministry of Health and to an extent the Ministry
of Agriculture.
‘We had a big push in the Ministry of Health although all ministries were fully involved
because our main stakeholder is the WHO and we are part of it. WHO brings us policies,
but it is up to us to adapt them. Alternatively, they bring you different models through
the Ministry of Health. So, the Ministry of Health was mobilised before mobilising other
sectors although the ministry of livestock and agriculture had its own guidelines.’ [AMR
Program Coordinator].
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Other donors and governmental bodies were mentioned as key stakeholders in the
NAP process by some interviewees.
‘The main stakeholders are, since the plan is about one health, ministries related to human
health and veterinary health and stakeholders involved in agriculture in general, as well
as various research institutions and professional institutions, such as SUA and MUHAS,
and development partners, such as the Global Development Organisation, Food and
Agriculture Organisation, and other stakeholders like the CDC.’ [FAO representative].
The role of international bodies and concomitant financial support for meeting atten-
dance was discussed by one interviewee.
‘International institutions were also part of the plan preparation; for example, we had rep-
resentatives from the FAO, WHO, OIE, and the World Animal Organisation, while there
were also interested parties like our partners from the American Society of Microbiology.
Moreover, I remember CDC were also there; they also facilitated and they supported
the meetings because participants had to travel, and I remember one of the sessions was
conducted in Morogoro, so people travelled from Dar es Salaam to Morogoro; so, they
were supporting us financially.’ [Ministry of Livestock and Fisheries representative].
These national and international bodies were generally perceived as supportive of
efforts around AMR, with very few critiques of the governmental or donor positions.
3. Discussion
In this study, we identified how different actors were framed by interviewees with
regard to their involvement in the response to AMR in Tanzania, while recognising that
those groups or actors that potentially influence policymaking are not necessarily coherent
epistemological communities. Our analysis suggests that the drivers of AMR in Tanzania
are multifaceted and complicated, and that no single ‘target population’ is believed to be
responsible for the spread of AMR in the country. Livestock farmers, pharmacies, medical
professionals, consumers in local communities, and the government were all mentioned as
bearing at least some of the responsibility for AMR. Human health is strongly emphasised
in policies and interventions, with a concomitant neglect of potential animal health and
environmental health drivers. This finding is replicated in other countries, for example,
Pakistan [3]. This emphasis on human health is likely to take resources, both human and
financial, away from the animal and environmental health sectors and focus political will on
human health, which is perceived as easier to address. Actions aimed at human health may
also be more visible and result in public approval of governmental policies. Interestingly,
many interviewees commented that political will is evinced by the Tanzanian government,
which appears keen to implement effective policymaking [14]. This is possibly a surprising
finding, as governmental support, although key to designing and implementing effective
policies to address AMR, is not often visible. Interestingly, a few interviewees discussed
the underlying lack of public health provision and infrastructure in Tanzania, although the
lack of sufficient laboratory diagnostic facilities was mentioned as a driver of the spread of
AMR, as this prevents a definite diagnosis and, thus, correct antibiotic prescription.
Stakeholders, drivers identified, and possible solutions are presented in Table 1.
3.1. How Does This Framing Inform Policymaking?
The most frequently discussed aspect of drivers of AMR in our interviews was ed-
ucation and lack of awareness, both in communities and in animal and human health
professionals. The general public was framed by some interviewees as being unaware of
the importance of, for example, finishing antibiotic courses, while others suggested that
people do understand the significance of their actions but are either uninterested in the
outcome of these or are unable to take them into consideration—for example, the livestock
farmer who ignores the antibiotic withdrawal period as they cannot afford not to sell the
animal’s meat or milk. This is related to the individual responsibility discourse, which
frames individual behaviour change as the key solution to the spread of AMR [20]. This is
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facile; it is too easy to frame taking or not taking antibiotics, finishing a course of antibiotics,
or not respecting a withdrawal period as individual responsibility, without taking into
account the multitude of other factors that drive behaviour. In a country like Tanzania, with
many other complicating issues such as antibiotic sales without a prescription [7] and a lack
of effective regulation of antibiotic use in humans and animals [8–11], this is particularly
unhelpful. It should be kept in mind that communities were perceived as having played no
part in the design of the AMR NAP. There was a general consensus among interviewees that
awareness is essential, although this does not necessarily translate into effective behaviour
change. A further issue is that it would be difficult to target an education or awareness
campaign at communities that may have very different backgrounds and understandings.
Table 1. Stakeholders, drivers, and solutions.
Stakeholder Driver Potential Solution
Livestock farmers Lack of awareness of AMR.
Enhance education programme; enforce relevant legislation on
sales of antimicrobials to farmers; reimbursement for farmers who
lose money as a result of the antibiotic withdrawal period.
Pharmacies Selling antibiotics over thecounter without a prescription.
Enforce inspections of pharmacy prescription records; match with
those from doctors.
Consumers Expectations of which antibioticshould be prescribed.
Improve awareness of AMR, i.e., why using the correct antibiotic
is important.
Medical professionals Wrongly prescribing as testsare expensive. Use inexpensive testing options.
Local communities Lack of engagement. Engage in planning/implementation.
Government
Lack of coordination among
human, animal, and
environmental health sectors.
Engage all sectors in planning and implementation of policies.
Donors Lack of programme longevity. Increase government budget for public health.
Although the Tanzanian Ministry of Health was widely perceived by interviewees
as playing the lead role in the formulation of the AMR NAP, international organisations
were framed as playing a significant role in the response to AMR in Tanzania. Funding
from international organisations is perceived as essential for any kind of response to issues
that should be addressed by national governments. One interviewee, whose job role was
focused on animal health, stated that human health is a priority. FAO provides financial
support for the implementation of NAPs and, therefore, has a voice in the process. Another
interviewee stated that the JEE findings, suggesting that Tanzania is not equipped to deal
effectively with AMR, were a strong catalyst for starting work on the plan. This implies that
indirect pressure has come from the international community. Similarly, donor funding
was seen by some interviewees as key to the successful implementation of any plan;
thus, if donors exit a country or withdraw funding, a huge financial resource disappears,
which will make implementation even more difficult. A 2020 report from the World Bank
suggested that Tanzania’s spend on health is insufficient to allow everyone to access quality
health services, and that per capita spend on health was 28.5 USD in 2017, an increase from
23.6 USD in 2010 [23]. The report also found that the health sector is over-reliant on donors,
with the government providing approximately 40% of the total spend on public health [24].
A more sustainable approach may be to use external consultants to inform local efforts
rather than being reliant on donors, who have their own interests and agendas. However,
some interviewees stated that there is a lot of political will from the Tanzanian government
to work toward addressing drivers of AMR in the country, and that this will may help to
an extent if donors stop funding projects.
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3.2. What Interventions May Be Effective When Targeted at Different Groups?
It is easier to target policies at groups who are viewed negatively and judged to be less
deserving of support (e.g., livestock farmers who ignore, for whatever reason, withdrawal
periods) rather than those who are generally positively viewed (e.g., doctors and medical
professionals). In addition, positively viewed groups have more power and influence and
may be able to deflect policies that are aimed at addressing their behaviours. This becomes
a vicious cycle, with positively viewed groups becoming more and more powerful and
more and more able to influence policymaking, supporting legislation that benefits them
and shooting down policy that does not. It then becomes much easier for authorities to
take the line of least resistance and target policies and interventions at weaker groups, for
example, consumers buying one or two antibiotics at a time. If the pharmacy selling them
these drugs is closed down as part of a programme of reform, poorer consumers are the
people who will suffer. Doctors are much less likely to be perceived as driven by personal
motivation than they are as people who care for others and have their best interests at heart.
Targeting policies at different groups, rather than a simplistic one-size-fits-all approach,
may help to promote robust and effective policies that will increase the likelihood of
success. Interventions must be realistic and tailored to the context in which they will be
implemented. The presence of political will and a respected and responsible government in
Tanzania, mentioned by some interviewees, will be key to successful policy implementation,
but this must also come with a financial commitment that is viable and does not rely too
much on donors. Collaborations among stakeholders representing different One Health
areas (human, animal, and environmental health) are going to be the cornerstone of any
effective policy designed to address the drivers of AMR in Tanzania. This is a complex
area; professionals are often siloed in their specialties and are reluctant to work with others.
A lack of consistent funding, while this may not be so much of an issue in Tanzania, must
also be taken into account. As discussed by most of the interviewees, the lack of awareness
of and education around AMR has to be addressed. The general public will not change
their behaviour unless they understand why doing so is essential, individually and at
the country level. Tackling AMR should be framed in a way that makes benefits to the
individual obvious.
Implementing, enforcing, and monitoring initiatives are also key to addressing AMR.
Pharmacists who sell antibiotics over the counter without a prescription, doctors who
prescribe without a laboratory report, and livestock owners who diagnose and treat their
cattle themselves must all be tackled. Context-specific monitoring and enforcement must
be put into place, and gaps and loopholes must be identified. For example, if a system
was initiated to allow prescriptions to be sent directly from a medical practice to a phar-
macy, there would be little room for dispensing error or amendment of prescriptions by
the consumer. Livestock farmers who forgo selling meat and milk until the antibiotic
withdrawal period has elapsed could be reimbursed by the government. A mixture of
education, awareness, and enforcement should be implemented to encourage everyone to
work together to slow down the spread of AMR in Tanzania.
3.3. Limitations of the Study
This was a qualitative study examining the perceptions of drivers of AMR in Tanzania
and, thus, we did not focus primarily on solutions to all the issues that were identified and
discussed in the interviews. We interviewed 114 people but recognise that their views may
not have been representative of their colleagues and other people involved in the same
field. This is a limitation common to all qualitative research.
4. Materials and Methods
4.1. Study Setting
This qualitative study was conducted in three districts in Tanzania in January and
February 2020. Ilala district was selected because it is a densely populated urban area with
a mixture of housing, agriculture, and industry, and it is heavily polluted with effluent from
Antibiotics 2021, 10, 991 14 of 16
abattoirs, domestic wastewater, and septic tanks and pit latrines [25,26]. The population
of Kibaha district is involved in large- and small-scale poultry and fish farming, which
may involve the use of antimicrobials [27,28]. Kilosa district has a large population of
pastoralists keeping cattle, sheep, and goats. This group is likely to self-treat their animals
using antimicrobials [29].
We used a purposive sampling strategy to identify key informants from national
government and health facilities in these districts. National policymakers were purposively
selected from the ministries responsible for Public Health, Livestock and Fisheries, and
Food and Agriculture. Other key informants were selected from the national regulatory
authorities and agencies. These key informants were selected because of their role in the
preparation and implementation of the NAP for AMR. At the facility and community
levels, we interviewed key informants including laboratory technicians, livestock officers,
paravets, healthcare facility managers, and pharmaceutical assistants and dispensers.
4.2. Data Collection
Two supervisors conducted a mapping exercise by visiting all three districts to identify
a list of potential key informants under the guidance of the district officials. Based on the list
of key informants generated from the mapping exercise and under the guidance of officials
from the district and ward/village levels, we conducted in-depth interviews with key
informants from the health, environment, and livestock and fishing sectors from national,
district, and lower (ward and village/street) levels. All participants gave informed consent
to be interviewed.
Face-to-face interviews were conducted in Kiswahili for 45 to 90 min. They were run
by 12 research assistants with undergraduate-level training in qualitative research and
coordinated by two researchers with postgraduate-level training in qualitative studies. The
researchers had no existing relationship with the interviewees. A topic guide was used
in the interviews, and interviewees were asked at the end of their interview whether they
had any further comments or whether they wanted to discuss anything that had not been
mentioned. All interviewees gave permission to record the interviews. Participants were
able to choose the location of the interview, which usually took place at their workplace. The
researchers took brief notes during the interview, and these were written up immediately
after each interview.
4.3. Data Management and Analysis
All interview transcripts were transcribed verbatim and translated from Kiswahili
into English. Some transcripts were back-translated to check that there was no loss of
the original meaning. We used a thematic data analysis approach, which applies both
inductive and deductive reasoning. A.D.B. and A.S.J. collectively identified and validated
themes across a sample of transcripts, reaching thematic saturation when no new themes
were apparent in the interviews [24]. A.D.B. and A.S.J. then conducted a line-by-line
analysis on all interview transcripts, using NVivo 12 qualitative data analysis software
(QSR International Pty Ltd., Melbourne, Australia, Version 12, 2018).
5. Conclusions
Our results suggest that many different groups help drive the spread of AMR in
Tanzania and need to be involved for any response to be effective. However, this is not yet
the case in Tanzania. Human health is currently perceived as driving the response, while
other domains lag behind in their efforts. Likewise, for AMR programmes and NAPs to
be successful, all sectors need to be involved, including civil society groups, community
representatives, and those working in communities (e.g., primary care physicians). Yet,
the NAP and current programmes largely fail to include these viewpoints. The perceived
presence of political will in Tanzania is a significant step toward such a response. Any
strategies to tackle AMR need to be tailored to the context-specific realities, taking into
account constraints, beliefs, and power dynamics within countries.
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